A Phase 3, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating the Efficacy and Safety of Empasiprubart IV in Adults With Chronic Inflammatory Demyelinating Polyneuropathy
A Phase 3, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating the Efficacy and Safety of Empasiprubart IV in Adults With Chronic Inflammatory Demyelinating Polyneuropathy
The main purpose of this study is to demonstrate the efficacy and safety of empasiprubart in adults with CIDP. The study consists of a part A where participants will either receive empasiprubart or placebo for 24 weeks (6 months). Following part A, participants will enter part B in which all participants will receive empasiprubart for 96 weeks (24 months).
More information can be found here: https://clinicaltrials.argenx.com/emnergize
Inclusion Criteria:
Exclusion Criteria:
clinicaltrials@argenx.com857-350-4834
Birmingham, Alabama 35233, United States
Rancho Mirage, California 92270, United States
smacwan@southlandneuromuscular.com; samirmacwan@gmail.com760-834-3540
Washington D.C., District of Columbia 20010, United States
Linz, Upper Austria 4021, Austria
Sofia, Sofia 1113, Bulgaria
Sofia, 1431, Bulgaria
Sofia, 1606, Bulgaria
Fuzhou, Fujian 350108, China
Alexandroupoli, Evros 68100, Greece
Gussago, Brescia 25064, Italy
Trieste, Friuli-VeneziaGiulia 34149, Italy
Genova, 16132, Italy
Trieste, 34149, Italy
Bunkyō-Ku, Tokyo 113-8519, Japan
London, WC1N3BG, United Kingdom
dstevens@csneuro.com719-389-1159
yasir.al-khalili@medstar.net857-350-4834
alerman@fcneurology.net954-243-5559
Matthew@aqualaneresearch.com650-723-6961
trickpatglynn@yahoo.com985-882-4500
sami.khella@pennmedicine.upenn.edu215-662-8870
clinicaltrials@argenx.com857-350-4834
yessar@austinneuromuscle.com512-920-0140
nicolas.nammour@sclamanagement.com281-579-6800
deabatoarg@gmail.com
bernardotentella@consultoriosintegrados.org
jakob.rath@meduniwien.ac.at+4314040031170
hamiltoncirne@gmail.com+55 61-99161-4490
marceloraffo82@gmail.com+55 (51) 3314-3209
pvsgobbi@gmail.com+551150845436
mdanovska@yahoo.com+359887381827
tsvetanovmd@mail.bg+359888677914
itournev@emhpf.org+359899844317
dr.m.i.dimitrova@gmail.com+359886850961
xcc198616@163.com+8613811624903
tcm2008@126.com+8613725137130
156760888@qq.com+862061641888
lzb88031347@126.com+862988330116
horakova.magda@fnbrno.cz+420734427851
katrin.gross-paju@astrakliinik.ee+37253323052
clinicaltrials@argenx.com857-350-4834
sacconi.s@chu-nice.fr+33492035757
dake58@mail.ru+995 577 413 466
kobaidze.guchi@gmail.com+995 595 252 925
info.sarion@gmail.com+995599167442
marikheladze@yahoo.com+995 595 040 101
ttsuladze@curatio.ge+995 599 156 391
temargania@yahoo.com+995577753204
kaxabra@gmail.com+995 599 542 236
mirandademuria@gmail.com+995 598 359 525
lstef.clinicaltr@gmail.com+302107289448
molnarmj@gmail.com
adie@hymc.gov.il+972 52 56103121
vincenzo.donadio@unibo.it+390514966113
Angelo.Schenone@unige.it+390103537065
previtali.stefano@hsr.it+390226433036
elisa.vegezzi@mondino.it+393487648786
alberto.benussi@units.it+390303995632
k-sato@sis.seirei.or.jp+81534741264
kanekochikako_chiken@yahoo.co.jp+81249345432
koike-haruki@med.nagoya-u.ac.jp+81952316511
vitalie.lisnic@usmf.md+373-79456641
oodainic@mail.ru+37379443354
w.l.vanderpol@umcutrecht.nl
marek.smilowski@neurologiaslaska.pl+48500282494
neurologiabk@su.krakow.pl+48 12 400 25 51
letitialapusneanu@yahoo.com+400740143118
dan.mitrea@neuroaxis.ro+40723226233
silviumanescu@yahoo.com+40722559718
albu.cecilia@yahoo.com+40740067124
koprusakova@gmail.com+421434203660
martin.suc@pentahospitals.sk+421566416813
erika.zacharova@pentahospitals.sk+421905729028
sueh916@gmail.com+821054056194
hllee@korea.ac.kr888888888
ryan.keh2@nca.nhs.uk+44 161 206 2427